The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
rhEPO-Global Market Insights and Sales Trends 2024
Synopsis
The process of supplying EPO externally, usually with the help of recombinant DNA technology in a cell culture, is known as rhEPO. rhEPO is used to treat anemia due to neural diseases, injuries, kidney diseases or cancer.
The global rhEPO market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of rhEPO in various end use industries. The expanding demands from the Hospitals and Retail Pharmacies, are propelling rhEPO market. ESRD, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Cancer segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for rhEPO market, driven by demand from China, the second largest economy with some signs of stabilising, the rhEPO market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for rhEPO, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global rhEPO market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global rhEPO market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, rhEPO sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of rhEPO covered in this report include 3SBio, Shanghai Chemo, Chengdu Diao, NCPC Genetech, Kyowa Hakko Kirin, Shandong Kexing, Ahua Pharmaceutical, Biosidus and Dragon Pharma, etc.
The global rhEPO market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
3SBio
Shanghai Chemo
Chengdu Diao
NCPC Genetech
Kyowa Hakko Kirin
Shandong Kexing
Ahua Pharmaceutical
Biosidus
Dragon Pharma
Global rhEPO market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global rhEPO market, Segment by Type:
ESRD
Cancer
HIV
Wounds and neural disease
Global rhEPO market, by Application
Hospitals
Retail Pharmacies
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of rhEPO manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of rhEPO in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The process of supplying EPO externally, usually with the help of recombinant DNA technology in a cell culture, is known as rhEPO. rhEPO is used to treat anemia due to neural diseases, injuries, kidney diseases or cancer.
The global rhEPO market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of rhEPO in various end use industries. The expanding demands from the Hospitals and Retail Pharmacies, are propelling rhEPO market. ESRD, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Cancer segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for rhEPO market, driven by demand from China, the second largest economy with some signs of stabilising, the rhEPO market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for rhEPO, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global rhEPO market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global rhEPO market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, rhEPO sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of rhEPO covered in this report include 3SBio, Shanghai Chemo, Chengdu Diao, NCPC Genetech, Kyowa Hakko Kirin, Shandong Kexing, Ahua Pharmaceutical, Biosidus and Dragon Pharma, etc.
The global rhEPO market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
3SBio
Shanghai Chemo
Chengdu Diao
NCPC Genetech
Kyowa Hakko Kirin
Shandong Kexing
Ahua Pharmaceutical
Biosidus
Dragon Pharma
Global rhEPO market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global rhEPO market, Segment by Type:
ESRD
Cancer
HIV
Wounds and neural disease
Global rhEPO market, by Application
Hospitals
Retail Pharmacies
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of rhEPO manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of rhEPO in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 rhEPO Market Overview
1.1 rhEPO Product Overview
1.2 rhEPO Market Segment by Type
1.2.1 ESRD
1.2.2 Cancer
1.2.3 HIV
1.2.4 Wounds and neural disease
1.3 Global rhEPO Market Size by Type
1.3.1 Global rhEPO Market Size Overview by Type (2018-2029)
1.3.2 Global rhEPO Historic Market Size Review by Type (2018-2023)
1.3.3 Global rhEPO Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America rhEPO Sales Breakdown by Type (2018-2023)
1.4.2 Europe rhEPO Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific rhEPO Sales Breakdown by Type (2018-2023)
1.4.4 Latin America rhEPO Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa rhEPO Sales Breakdown by Type (2018-2023)
2 Global rhEPO Market Competition by Company
2.1 Global Top Players by rhEPO Sales (2018-2023)
2.2 Global Top Players by rhEPO Revenue (2018-2023)
2.3 Global Top Players by rhEPO Price (2018-2023)
2.4 Global Top Manufacturers rhEPO Manufacturing Base Distribution, Sales Area, Product Type
2.5 rhEPO Market Competitive Situation and Trends
2.5.1 rhEPO Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by rhEPO Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in rhEPO as of 2022)
2.7 Date of Key Manufacturers Enter into rhEPO Market
2.8 Key Manufacturers rhEPO Product Offered
2.9 Mergers & Acquisitions, Expansion
3 rhEPO Status and Outlook by Region
3.1 Global rhEPO Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global rhEPO Historic Market Size by Region
3.2.1 Global rhEPO Sales in Volume by Region (2018-2023)
3.2.2 Global rhEPO Sales in Value by Region (2018-2023)
3.2.3 Global rhEPO Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global rhEPO Forecasted Market Size by Region
3.3.1 Global rhEPO Sales in Volume by Region (2024-2029)
3.3.2 Global rhEPO Sales in Value by Region (2024-2029)
3.3.3 Global rhEPO Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global rhEPO by Application
4.1 rhEPO Market Segment by Application
4.1.1 Hospitals
4.1.2 Retail Pharmacies
4.2 Global rhEPO Market Size by Application
4.2.1 Global rhEPO Market Size Overview by Application (2018-2029)
4.2.2 Global rhEPO Historic Market Size Review by Application (2018-2023)
4.2.3 Global rhEPO Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America rhEPO Sales Breakdown by Application (2018-2023)
4.3.2 Europe rhEPO Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific rhEPO Sales Breakdown by Application (2018-2023)
4.3.4 Latin America rhEPO Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa rhEPO Sales Breakdown by Application (2018-2023)
5 North America rhEPO by Country
5.1 North America rhEPO Historic Market Size by Country
5.1.1 North America rhEPO Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America rhEPO Sales in Volume by Country (2018-2023)
5.1.3 North America rhEPO Sales in Value by Country (2018-2023)
5.2 North America rhEPO Forecasted Market Size by Country
5.2.1 North America rhEPO Sales in Volume by Country (2024-2029)
5.2.2 North America rhEPO Sales in Value by Country (2024-2029)
6 Europe rhEPO by Country
6.1 Europe rhEPO Historic Market Size by Country
6.1.1 Europe rhEPO Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe rhEPO Sales in Volume by Country (2018-2023)
6.1.3 Europe rhEPO Sales in Value by Country (2018-2023)
6.2 Europe rhEPO Forecasted Market Size by Country
6.2.1 Europe rhEPO Sales in Volume by Country (2024-2029)
6.2.2 Europe rhEPO Sales in Value by Country (2024-2029)
7 Asia-Pacific rhEPO by Region
7.1 Asia-Pacific rhEPO Historic Market Size by Region
7.1.1 Asia-Pacific rhEPO Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific rhEPO Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific rhEPO Sales in Value by Region (2018-2023)
7.2 Asia-Pacific rhEPO Forecasted Market Size by Region
7.2.1 Asia-Pacific rhEPO Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific rhEPO Sales in Value by Region (2024-2029)
8 Latin America rhEPO by Country
8.1 Latin America rhEPO Historic Market Size by Country
8.1.1 Latin America rhEPO Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America rhEPO Sales in Volume by Country (2018-2023)
8.1.3 Latin America rhEPO Sales in Value by Country (2018-2023)
8.2 Latin America rhEPO Forecasted Market Size by Country
8.2.1 Latin America rhEPO Sales in Volume by Country (2024-2029)
8.2.2 Latin America rhEPO Sales in Value by Country (2024-2029)
9 Middle East and Africa rhEPO by Country
9.1 Middle East and Africa rhEPO Historic Market Size by Country
9.1.1 Middle East and Africa rhEPO Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa rhEPO Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa rhEPO Sales in Value by Country (2018-2023)
9.2 Middle East and Africa rhEPO Forecasted Market Size by Country
9.2.1 Middle East and Africa rhEPO Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa rhEPO Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 3SBio
10.1.1 3SBio Company Information
10.1.2 3SBio Introduction and Business Overview
10.1.3 3SBio rhEPO Sales, Revenue and Gross Margin (2018-2023)
10.1.4 3SBio rhEPO Products Offered
10.1.5 3SBio Recent Development
10.2 Shanghai Chemo
10.2.1 Shanghai Chemo Company Information
10.2.2 Shanghai Chemo Introduction and Business Overview
10.2.3 Shanghai Chemo rhEPO Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Shanghai Chemo rhEPO Products Offered
10.2.5 Shanghai Chemo Recent Development
10.3 Chengdu Diao
10.3.1 Chengdu Diao Company Information
10.3.2 Chengdu Diao Introduction and Business Overview
10.3.3 Chengdu Diao rhEPO Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Chengdu Diao rhEPO Products Offered
10.3.5 Chengdu Diao Recent Development
10.4 NCPC Genetech
10.4.1 NCPC Genetech Company Information
10.4.2 NCPC Genetech Introduction and Business Overview
10.4.3 NCPC Genetech rhEPO Sales, Revenue and Gross Margin (2018-2023)
10.4.4 NCPC Genetech rhEPO Products Offered
10.4.5 NCPC Genetech Recent Development
10.5 Kyowa Hakko Kirin
10.5.1 Kyowa Hakko Kirin Company Information
10.5.2 Kyowa Hakko Kirin Introduction and Business Overview
10.5.3 Kyowa Hakko Kirin rhEPO Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Kyowa Hakko Kirin rhEPO Products Offered
10.5.5 Kyowa Hakko Kirin Recent Development
10.6 Shandong Kexing
10.6.1 Shandong Kexing Company Information
10.6.2 Shandong Kexing Introduction and Business Overview
10.6.3 Shandong Kexing rhEPO Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Shandong Kexing rhEPO Products Offered
10.6.5 Shandong Kexing Recent Development
10.7 Ahua Pharmaceutical
10.7.1 Ahua Pharmaceutical Company Information
10.7.2 Ahua Pharmaceutical Introduction and Business Overview
10.7.3 Ahua Pharmaceutical rhEPO Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Ahua Pharmaceutical rhEPO Products Offered
10.7.5 Ahua Pharmaceutical Recent Development
10.8 Biosidus
10.8.1 Biosidus Company Information
10.8.2 Biosidus Introduction and Business Overview
10.8.3 Biosidus rhEPO Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Biosidus rhEPO Products Offered
10.8.5 Biosidus Recent Development
10.9 Dragon Pharma
10.9.1 Dragon Pharma Company Information
10.9.2 Dragon Pharma Introduction and Business Overview
10.9.3 Dragon Pharma rhEPO Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Dragon Pharma rhEPO Products Offered
10.9.5 Dragon Pharma Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 rhEPO Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 rhEPO Industrial Chain Analysis
11.4 rhEPO Market Dynamics
11.4.1 rhEPO Industry Trends
11.4.2 rhEPO Market Drivers
11.4.3 rhEPO Market Challenges
11.4.4 rhEPO Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 rhEPO Distributors
12.3 rhEPO Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
